Search Results - "Spadafora, Luigi"

Hemoglobin-to-Creatinine Ratio Predicts One-Year Adverse Clinical Outcomes in ST-Elevation Myocardial Infarction: Retrospective and Propensity Score Matched Analysis.

Authors: Spadafora, Luigi Cacciatore, Stefano Galli, Mattia et al.

Source: Journal of Clinical Medicine. Apr2025, Vol. 14 Issue 8, p2756. 15p.

Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults.

Authors: Bernardi, Marco Spadafora, Luigi Andaloro, Silvia et al.

Source: Journal of Clinical Medicine. Jun2024, Vol. 13 Issue 11, p3064. 16p.

Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.

Authors: Spadafora, Luigi Russo, Federico Bukowska-Olech, Ewelina et al.

Source: American Journal of Cardiovascular Drugs. Jan2026, Vol. 26 Issue 1, p21-34. 14p.

Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence.

Authors: Cacciatore, Stefano Spadafora, Luigi Bernardi, Marco et al.

Source: Journal of Clinical Medicine. Aug2023, Vol. 12 Issue 16, p5233. 19p.

One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE Registry.

Authors: Spadafora, Luigi Pastena, Paola Cacciatore, Stefano et al.

Source: American Journal of Cardiovascular Drugs. Sep2025, Vol. 25 Issue 5, p681-691. 11p.

Functional Mitral Regurgitation in the Transcatheter Era: Diagnostic and Therapeutic Pathways.

Authors: Di Muro, Francesca Maria Spadafora, Luigi Buonpane, Angela et al.

Source: Journal of Personalized Medicine. Aug2025, Vol. 15 Issue 8, p372. 26p.

Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence.

Authors: Abu Suleiman, Amro Quagliariello, Vincenzo Spadafora, Luigi et al.

Source: Pharmaceuticals (14248247). Jun2026, Vol. 19 Issue 6, p833. 21p.

Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?

Authors: Bernardi, Marco Spadafora, Luigi Galli, Mattia et al.

Source: Archives of Medical Science. 2023, Vol. 19 Issue 2, p528-531. 4p.

Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies.

Authors: Iervolino, Adelaide Spadafora, Luigi Spadaccio, Cristiano et al.

Source: Pharmaceutics. Jan2023, Vol. 15 Issue 1, p87. 19p.

Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies.

Authors: Spadafora, Luigi Bernardi, Marco Galli, Mattia et al.

Source: Archives of Medical Science. 2022, Vol. 18 Issue 6, p1689-1692. 4p.

Vitamin D and Cardiovascular Disease: The "Good", the "Bad", and the "Unknown".

Authors: Giamundo, Domenico Mario Morello, Matteo Pastena, Paola et al.

Source: Reviews in Cardiovascular Medicine. Oct2025, Vol. 26 Issue 10, p1-17.

Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients.

Authors: Spadafora, Luigi Bernardi, Marco Sarto, Gianmarco et al.

Source: American Journal of Cardiovascular Drugs. Jul2024, Vol. 24 Issue 4, p469-479. 11p.

De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?

Authors: Sabouret, Pierre Spadafora, Luigi Fischman, David et al.

Source: European Journal of Internal Medicine. Apr2023, Vol. 110, p1-9. 9p.

The cardiologist's commandment: Thou shalt not retract!

Authors: Spadafora, Luigi Testa, Alberto Frati, Giacomo et al.

Source: International Journal of Cardiology. Mar2022, Vol. 350, p106-108. 3p.

Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies.

Authors: Sabouret, Pierre Giamundo, Domenico Mario Costa, Francesco et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2325. 18p.

Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience.

Authors: Serapide, Francesca Serraino, Riccardo Spadafora, Luigi et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). May2025, Vol. 80 Issue 5, p1241-1247. 7p.

Juvenile myocardial infarction: Sex matters.

Authors: Bernardi, Marco Spadafora, Luigi Biondi-Zoccai, Giuseppe et al.

Source: International Journal of Cardiology. Aug2022, Vol. 361, p18-19. 2p.

Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management.

Authors: Cacciatore, Stefano Andaloro, Silvia Bernardi, Marco et al.

Source: International Journal of Molecular Sciences. Apr2025, Vol. 26 Issue 7, p3071. 31p.

Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?

Authors: Giordano, Salvatore Camera, Marina Brambilla, Marta et al.

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p1136. 24p.

Role of nutrition and healthy lifestyle, for individuals in primary prevention: recent data, gaps in evidence and future directions.

Authors: Metsovitis, Theodora Bernardi, Marco Bruckert, Eric et al.

Source: Archives of Medical Science. 2024, Vol. 20 Issue 5, p1385-1399. 15p.